A comparison of medical versus surgical treatment in Barrett's oesophagus acid control

Attwood, 2008, Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience, J Gastrointest Surg, 12, 1646, 10.1007/s11605-008-0645-1 Spechler, 2011, American Gastroenterological Association technical review on the management of Barrett's esophagus, Gastroenterology, 140, e18, 10.1053/j.gastro.2011.01.031 Anaparthy, 2013, Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia, Clin Gastroenterol Hepatol, 11, 1430, 10.1016/j.cgh.2013.05.007 Singh, 2014, Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis, Gut, 63, 1229, 10.1136/gutjnl-2013-305997 Committee ASoP, 2012, The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus, Gastrointest Endosc, 76, 1087, 10.1016/j.gie.2012.08.004 Spechler, 2013, Barrett esophagus and risk of esophageal cancer: a clinical review, JAMA, 310, 627, 10.1001/jama.2013.226450 El-Serag, 2014, Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study, Gut, 63, 220, 10.1136/gutjnl-2012-304189 Wassenaar, 2010, Effect of medical and surgical treatment of Barrett's metaplasia, World J Gastroenterol, 16, 3773, 10.3748/wjg.v16.i30.3773 Spechler, 2006, Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial, Am J Gastroenterol, 101, 1964, 10.1111/j.1572-0241.2006.00661.x Kastelein, 2013, Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus, Clin Gastroenterol Hepatol, 11, 382, 10.1016/j.cgh.2012.11.014 Sarela, 2004, Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy, Arch Surg, 139, 547, 10.1001/archsurg.139.5.547 Oberg, 2005, Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma, Ann Surg, 242, 49, 10.1097/01.sla.0000167864.46462.9f Spechler, 2001, Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial, JAMA, 285, 2331, 10.1001/jama.285.18.2331 Kahrilas, 2008, American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease, Gastroenterology, 135, 1383, 10.1053/j.gastro.2008.08.045 Badillo, 2014, Diagnosis and treatment of gastroesophageal reflux disease, World J Gastrointest Pharmacol Ther, 5, 105, 10.4292/wjgpt.v5.i3.105 Helman, 2012, Esophageal manometry findings and degree of acid exposure in short and long Barrett's esophagus, Arq Gastroenterol, 49, 64, 10.1590/S0004-28032012000100011 Loughney, 1998, Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus, Am J Gastroenterol, 93, 916, 10.1111/j.1572-0241.1998.00276.x Zaninotto, 2012, Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy, J Gastrointest Surg, 16, 7, 10.1007/s11605-011-1739-8 Mackalski, 2008, Esophageal pH testing in patients refractory to proton pump inhibitor therapy, Can J Gastroenterol, 22, 249, 10.1155/2008/862302 Watson, 2013, The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus, Dig Dis Sci, 58, 2253, 10.1007/s10620-013-2763-1 Parrilla, 2003, Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus, Ann Surg, 237, 291, 10.1097/01.SLA.0000055269.77838.8E Hofstetter, 2001, Long-term outcome of antireflux surgery in patients with Barrett's esophagus, Ann Surg, 234, 532, 10.1097/00000658-200110000-00012 Chang, 2007, The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review, Ann Surg, 246, 11, 10.1097/01.sla.0000261459.10565.e9 Trad, 2015, Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial, Surg Innov, 22, 26, 10.1177/1553350614526788 Hunter, 2015, Efficacy of transoral fundoplication vs. omeprazole for treatment of regurgitation in a randomized controlled trial, Gastroenterology, 148, 10.1053/j.gastro.2014.10.009 Oelschlager, 2003, Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery, Ann Surg, 238, 458, 10.1097/01.sla.0000090443.97693.c3 Gerson, 2004, Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors, Aliment Pharmacol Ther, 20, 637, 10.1111/j.1365-2036.2004.02127.x Gerson, 2005, Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus, Dig Liver Dis, 37, 651, 10.1016/j.dld.2005.04.013